A Study to Evaluate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics Of AJ201 In Patients

Clinical trial NCT05517603 · COMPLETED

Trial details

NCT number: NCT05517603
Sponsor: AnnJi Pharmaceutical Co., Ltd.
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Spinal and Bulbar Muscular Atrophy Kennedy's Disease

Start date: 2023-02-28
Primary completion: 2024-04-08
Enrollment: 25

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.